David Rooklin: His Scientific Research, Redesign Science and Ilana Glazer

David Rooklin is a scientist and biotech founder who works on computer tools for drug research. He is the co-founder and chief executive of Redesign Science, a New York company that studies how small molecules may bind to proteins. He is also married to comedian and actor Ilana Glazer.

Many readers first hear his name through Glazer, the co-creator of Broad City. His own work tells a different story. It brings together chemistry, computer models, and the search for new drugs. His published studies help show what he did before starting a company.

In this article, you’ll learn about Rooklin’s training, his research on protein surfaces, the work of Redesign Science, and the public facts about his marriage and family.

David Rooklin’S Education and Research Path

Rooklin studied biochemistry at Oberlin College. He later earned a PhD at New York University in 2012. His studies brought him into a field that uses math and computer tools to ask questions about living things.

A protein is a tiny part of the body that does many jobs. Its shape matters. So does the way it moves and meets other molecules. Scientists can study those changes in a lab, but they can also build computer models to test ideas before doing more lab work.

Rooklin worked with the research group led by Yingkai Zhang at NYU. The group’s alumni list records his PhD and later work there. It also names him as the chief executive of Redesign Science. That record links his early lab work with the business he later helped build.

What His AlphaSpace Research Tried to Solve

One of Rooklin’s best known research projects is AlphaSpace. In 2015, he and other scientists published a paper about this tool. It was made to study the surfaces where proteins meet. Those surfaces can be hard places for a drug to act.

Think of two pieces that touch along a broad edge. It may be hard to find a small spot where a new piece can fit. Some protein pairs pose a similar problem. Their contact areas may not have the deep pockets that many small drug molecules need.

AlphaSpace helps map small regions of those surfaces. The goal is to spot places that may hold a chemical fragment. That gives researchers a way to ask which areas are worth a closer look. It does not prove that a drug will work in a patient.

This distinction is key. A computer can help find a promising site, but a useful medicine must pass many tests. Scientists still need to check how a compound acts in cells, whether it is safe, and what happens in trials. A good map is one step in a much longer path.

From a University Project to a Company

In 2016, a Redesign Science team won the technology prize in an NYU Stern business contest. The university described a plan to use virtual design to find and improve compounds that act on protein pairs. Rooklin was named with Ashley Modell and Joseph Katigbak on that early team.

The contest mattered because it joined a science idea with a business plan. A lab tool can be useful to researchers without becoming a product. A company must also decide how to build the tool, pay for the work, and test whether other teams can use it.

Redesign Science was founded in 2017. Rooklin has been identified as its co-founder and chief executive. The firm works in early drug research, where teams try to find compounds that may one day become treatments. Its focus is on hard protein targets and the way they change shape.

What Redesign Science Does

The company uses computer models to study proteins at a very small scale. A protein is not a still object. It can bend and shift as it does its work. A model that treats it as frozen may miss a spot where a small molecule could bind.

Redesign Science combines physics-based models with machine learning. Its goal is to explore the many shapes a protein can take and find possible drug sites. The NYU technology profile describes this work and names Rooklin as a principal investigator.

The firm calls its platform NUVO. It uses simulation and AI tools to help search for compounds. In plain terms, the software can help a research team choose which chemical ideas deserve more work. That can be useful because the number of possible molecules is vast.

There is an important limit to this claim. Finding a good match on a computer does not mean a new drug has been approved. Lab tests, animal studies where required, and human trials can still reveal problems. Redesign Science works near the start of that process.

Why Protein Motion Matters

Many pictures of proteins show one neat shape. Real proteins move. A small shift can open a space that was not clear in the first picture. It can also close a space or change the way a drug might fit.

This is why simulation can help. Instead of looking at one pose, researchers can study a set of likely shapes. They can then ask whether a molecule could bind to one of them. The work still needs real tests, but it may point the lab toward better ideas.

Rooklin’s earlier work on AlphaSpace and his later company share this broad aim. Both ask how to find useful places on proteins that are not easy to target. The methods have changed over time, but the problem remains a hard one.

What His Work Means for Drug Research

Drug discovery often starts with a question about disease. Scientists may find a protein linked to a harmful process. They then need a way to change what that protein does. That can be hard even when they know a lot about the disease.

Computer tools do not remove that challenge. They help sort ideas. A model can suggest a site to test or a compound to make. A lab can then check whether the idea holds up. Each step can rule out weak choices and point to new ones.

Rooklin’s career shows how work done in a university lab can lead to a new business. It also shows why science news needs care. A strong research tool is worth noting, but it is not the same as a proven treatment.

Marriage to Ilana Glazer and Family Life

Rooklin is married to Ilana Glazer, known for Broad City and her work in comedy. They met in New York in 2012 and married in February 2017. Glazer has spoken in public about their relationship, while Rooklin has kept most of his personal life away from the spotlight.

The couple welcomed a daughter in 2021. They have not made her private details the focus of public life. People’s profile covers the marriage, his work, and their family. It offers a better guide than sites that guess about their home or finances.

Their careers are very different, but both involve creative work. Glazer writes and performs for an audience. Rooklin leads research that tries to solve problems in chemistry and biology. It is possible to understand his career without treating him only as a celebrity spouse.

Frequently Asked Questions (FAQs)

Who Is David Rooklin?

David Rooklin is a scientist and biotech entrepreneur. He leads Redesign Science and is married to comedian Ilana Glazer.

What Does David Rooklin Do for Work?

He works on computer methods used in early drug discovery. His company studies proteins and possible places where small molecules could bind.

Where Did David Rooklin Study?

He studied biochemistry at Oberlin College and earned a PhD from New York University in 2012.

What Is AlphaSpace?

AlphaSpace is a research tool that maps parts of protein surfaces. It helps scientists look for spots that may be useful when designing molecules.

When Did David Rooklin Marry Ilana Glazer?

The couple married in February 2017. They welcomed a daughter in 2021 and keep much of their family life private.

Final Thoughts

David Rooklin’s public story has two sides. One is his marriage to a well known comedian. The other is a record of science work that led from NYU research to a biotech company.

His work is best understood as part of the long search for better ways to study proteins and test drug ideas. It offers a clear example of how computer science can support lab research without taking the place of it.

You may also read: Tasha McCauley: Robotics, AI Leadership and Family Life